You can't really blame them for both an increase in inventories AND the increase in payables / current liabilities and say it's not actual value created by the company.
That would be selective accounting, they bought ore cheap and had to write its value up, well, because the value of that ore increased and they used payable and liabilities to achieve that.
You get it one way, either you count the increase in payables and count the ore write up, or you don't count either.
Not sure why you would count out the 12m$ impairment out of the operating profit either, this is a result of the depreciation of assets already bought, this doesn't affect cash balance at all. They could have put 5$ or 30m$ and this wouldn't have affected cashflow outside of taxes no ?
I'm not an expert in accounting but the proof is in the pudding, they have substantially reduced their debt, substantially increased their asset backing, and done a 180m$au acquisition in the last 3 years. Surely this can't be the result of accounting footwork.
- Forums
- ASX - By Stock
- Ann: 2024 Half Year NPAT US$12.9 million
You can't really blame them for both an increase in inventories...
Featured News
Add OMH (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $264.3M |
Open | High | Low | Value | Volume |
33.5¢ | 34.5¢ | 33.5¢ | $2.017K | 6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 11000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1515 | 0.330 |
2 | 11611 | 0.320 |
2 | 4280 | 0.305 |
1 | 3400 | 0.290 |
1 | 5000 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 116007 | 3 |
0.375 | 2000 | 1 |
0.385 | 44943 | 1 |
0.395 | 56872 | 1 |
0.455 | 6528 | 1 |
Last trade - 15.34pm 15/11/2024 (20 minute delay) ? |
Featured News
OMH (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online